01286nam a2200241   45000010005000000100015000051000041000201010008000612000159000692100083002282150023003112250033003343000086003673300382004536060022008356060021008576060024008786060019009026060021009216060022009427100069009648520011010337598  a9291681377  a20030502d2003       y0pory50      ba  aeng  aReport on the risk assessment of PMMA in the framework of the joint action on new synthetic drugsfEuropean Monitoring Centre for Drugs and Drug Addiction  aLuxembourgcOffice for Official Publications of the European Communitiesd2003  a122 p.cil.d21 cm  aEMCDDA - Risk Assessmentsv5  aInformação sobre EMCDDA pode ser encontrada no site: https://www.emcdda.eu.int  aReport on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs. Council decision. Europol-EMCDDA progress report on PMMA and PMA. Review of the pharmacotoxicological data on PMMA. Sociological and criminological evidence on the risks of PMMA. Public health risks of PMMA: epidemiological evidence. Participants in the risk assessment process.  aSAÚDE PÚBLICA  aCONSUMO DE DROGA  aTOXICODEPENDÊNCIA  aTIPOS DE DROGA  aUNIÃO EUROPEIA  aRELATÓRIO ANUAL  aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION - EMCDDA  jDRO210